Life-threatening complications of adult-onset Still's disease

scientific article

Life-threatening complications of adult-onset Still's disease is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1007/S10067-014-2487-4
P932PMC publication ID7102228
P698PubMed publication ID24435354

P2093author name stringPetros Efthimiou
Bella Mehta
Sabeeda Kadavath
P2860cites workAdult-onset Still's diseaseQ80354973
Leflunomide and methotrexate combination in refractory adult-onset Still's diseaseQ80400099
Adalimumab (anti-TNF-alpha) therapy to improve the clinical course of adult-onset Still's disease: the first case reportQ81238130
Adult-onset Still's diseaseQ82285530
Pulmonary hypertension in systemic sclerosisQ82294311
Macrophage activation syndrome associated with etanercept in a child with systemic onset juvenile idiopathic arthritisQ82530778
Rapid and sustained remission of systemic juvenile idiopathic arthritis-associated macrophage activation syndrome through treatment with anakinra and corticosteroidsQ82950882
Combination therapy of abatacept and anakinra in children with refractory systemic juvenile idiopathic arthritis: a retrospective case seriesQ83084990
Glucocorticoid and cyclosporine refractory adult onset Still's disease successfully treated with tocilizumabQ83274923
Macrophage activation syndrome treated with anakinraQ83975572
Selective endothelin A receptor antagonism with sitaxsentan for pulmonary arterial hypertension associated with connective tissue diseaseQ24681558
Adult-onset Still's disease with disseminated intravascular coagulation and multiple organ dysfunctions dramatically treated with cyclosporine AQ28167268
Adult-onset Still disease presenting with disseminated intravascular coagulationQ28168791
Thrombotic microangiopathy, hemolytic uremic syndrome, and thrombotic thrombocytopenic purpuraQ28214974
Macrophage activation syndrome: a potentially fatal complication of rheumatic disordersQ28362327
Continuous intravenous epoprostenol for pulmonary hypertension due to the scleroderma spectrum of disease. A randomized, controlled trialQ28374317
Chronic relapsing thrombotic thrombocytopenic purpura in adult onset Still's diseaseQ33346657
Effect of plasma exchange on plasma ADAMTS13 metalloprotease activity, inhibitor level, and clinical outcome in patients with idiopathic and nonidiopathic thrombotic thrombocytopenic purpura.Q33359709
Response to plasma exchange and splenectomy in thrombotic thrombocytopenic purpura. A 10-year experience at a single institutionQ33364030
Reactive haemophagocytic syndrome in adult-onset Still's disease: a report of six patients and a review of the literatureQ33370577
Thrombotic thrombocytopenic purpura-hemolytic uremic syndrome and adult onset Still's disease: case report and review of the literatureQ33379355
Thrombotic thrombocytopenic purpura and adult onset Still's diseaseQ33383879
Thrombotic microangiopathy and purtscher-like retinopathy associated with adult-onset Still's disease: a role for glomerular vascular endothelial growth factor?Q33386885
Etanercept-refractory adult-onset Still's disease with thrombotic thrombocytopenic purpura successfully treated with tocilizumabQ33388583
A case of adult-onset Still's disease complicated by thrombotic thrombocytopenic purpura with retinal microangiopathy and rapidly fatal cerebral edemaQ33401390
Enhanced plasminogen-activator production by leukocytes in the human and murine Chediak-Higashi syndromeQ33460119
Anti-CD36 antibodies in thrombotic thrombocytopenic purpuraQ33488104
Cyclosporine therapy of adult onset Still's disease with disseminated intravascular coagulationQ33494769
von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura and the hemolytic-uremic syndromeQ33504463
Treatment of pulmonary hypertension secondary to connective tissue diseases.Q33634193
Pulmonary involvement in adult-onset Still's diseaseQ33719785
Adult-onset Still's disease. Clinical course and outcomeQ34191960
Preliminary criteria for classification of adult Still's diseaseQ34405573
Adult-onset Still's disease: can recent advances in our understanding of its pathogenesis lead to targeted therapy?Q34632947
Efficacy, safety and tolerability of tocilizumab in patients with systemic juvenile idiopathic arthritisQ34646212
Liver abnormalities in rheumatic diseasesQ35040109
Retrospective monocentric study of 17 patients with adult Still's disease, with special focus on liver abnormalities.Q35082963
Successful treatment of a small cohort of patients with adult onset of Still's disease with infliximab: first experiencesQ35579173
Diagnosis and management of adult onset Still's diseaseQ35637158
Bosentan treatment for pulmonary arterial hypertension related to connective tissue disease: a subgroup analysis of the pivotal clinical trials and their open-label extensions.Q35637949
Tocilizumab for the treatment of rheumatoid arthritis and other systemic autoimmune diseases: current perspectives and future directionsQ35724900
Drug-induced diffuse alveolar hemorrhage syndromes and vasculitisQ35737068
Severe imbalance of IL-18/IL-18BP in patients with secondary hemophagocytic syndromeQ35847631
Diffuse alveolar hemorrhageQ35872280
Interleukin-6: from basic science to medicine--40 years in immunologyQ36072403
Preliminary diagnostic guidelines for macrophage activation syndrome complicating systemic juvenile idiopathic arthritisQ36116060
Pulmonary Arterial Hypertension in Adult-Onset Still's Disease: Rapid Response to Anakinra.Q36220786
Pathogenesis and management of adult-onset Still's diseaseQ36583909
Predictors of mortality in connective tissue disease-associated pulmonary arterial hypertension: a cohort studyQ36633190
Anakinra in patients with treatment-resistant adult-onset Still's disease: four case reports with serial cytokine measurements and a review of the literature.Q36855193
Adult-onset Still's disease: pathogenesis, clinical manifestations and therapeutic advancesQ37079113
A case of adult-onset Still's disease complicated with diffuse alveolar hemorrhage.Q37116890
Adult-onset Still diseaseQ37333091
Adult Still's disease: manifestations, disease course, and outcome in 62 patientsQ37670649
An international consensus survey of diagnostic criteria for macrophage activation syndrome in systemic juvenile idiopathic arthritis.Q37834144
The use of Canakinumab, a novel IL-1β long-acting inhibitor, in refractory adult-onset Still's diseaseQ38003501
Biological treatment in adult-onset Still's diseaseQ38049762
Adult onset Still's disease: experience in 23 patients and literature review with emphasis on organ failureQ39667880
Adult Still's disease: review of 228 cases from the literatureQ39694157
Randomized trial of tocilizumab in systemic juvenile idiopathic arthritisQ40263864
Adult-Onset Still's Disease Masquerading as Sepsis in an Asplenic Active Duty SoldierQ40263935
Relapsing macrophage activating syndrome in a 15-year-old girl with Still's disease: a case reportQ40369117
Fatal myocarditis in adult-onset Still disease with diffuse intravascular coagulation.Q40403433
A case of macrophage activation syndrome successfully treated with anakinraQ40408368
Etanercept as a rescue agent in patient with adult onset Still's disease complicated with congestive heart failure.Q40418487
Adult onset Still's disease: a study of 14 casesQ40441853
Occult macrophage activation syndrome in patients with systemic juvenile idiopathic arthritis.Q40455988
Hemophagocytic syndrome in one patient with adult-onset Still's disease. Presentation with febrile neutropeniaQ40483423
Acute respiratory failure revealing adult-onset Still's disease: diagnostic value of low glycosylated ferritin levelQ40494122
Rapid responses to anakinra in patients with refractory adult-onset Still's diseaseQ40507008
Macrophage activation syndrome associated with systemic juvenile idiopathic arthritisQ40518260
Clinical manifestations, disease course, and complications of adult-onset Still's disease in TaiwanQ40520885
Disseminated intravascular coagulation in a case of adult onset Still's diseaseQ40643502
A case of hemophagocytic syndrome with severe liver injury manifestating adult Still's diseaseQ40644635
A case of adult onset Still's disease complicated with adult respiratory distress syndrome and disseminated intravascular coagulationQ40687328
A case of adult Still's disease with pulmonary hypertensionQ40765056
Interleukin-6 in biology and medicineQ40850225
Adult Still's diseaseQ40860971
Comparison of long term evolution of adult onset and juvenile onset Still's disease, both followed up for more than 10 yearsQ41221844
Successful treatment of refractory adult onset Still's disease with rituximabQ42955722
Which patients stop working because of RA?Q43050973
Guidelines for the diagnosis and treatment of pulmonary hypertensionQ43141520
Non-infectious mitral endocarditis during Still's disease in adults. A case with histologic study of the endocardiumQ44134375
Efficacy of thalidomide in refractory adult Still's disease: a new case reportQ44441205
Efficacy of traditional and biologic agents in different clinical phenotypes of adult-onset Still's diseaseQ44554787
Worsening of macrophage activation syndrome in a patient with adult onset Still's disease after initiation of etanercept therapyQ44924027
Treprostinil, a prostacyclin analogue, in pulmonary arterial hypertension associated with connective tissue disease.Q45012569
Leflunomide and azathioprine combination in refractory adult-onset Still's diseaseQ45291859
Macrophage activation syndrome: a frequent but under-diagnosed complication associated with rheumatic diseasesQ46732683
Sildenafil for pulmonary arterial hypertension associated with connective tissue diseaseQ46912711
Macrophage activation syndrome and etanercept in children with systemic juvenile rheumatoid arthritisQ48012891
Gene expression profiling of peripheral blood from patients with untreated new-onset systemic juvenile idiopathic arthritis reveals molecular heterogeneity that may predict macrophage activation syndrome.Q50672047
Benefit and a possible risk of tocilizumab therapy for adult-onset Still’s disease accompanied by macrophage-activation syndromeQ51545663
Pulmonary arterial hypertension in autoimmune diseases: an analysis of 19 cases from a medical center in northern Taiwan.Q51811224
Pulmonary hypertension in collagen vascular diseaseQ57824393
[Adult onset Still's disease revealed by a myocarditis]Q64039734
Pulmonary arterial hypertension complicating adult-onset Still's diseaseQ64043572
The biology of interleukin-6Q69086773
[Still's disease in adults with disseminated intravascular coagulation]Q70152170
Chronic liver disease and Still's diseaseQ70365127
Fulminant hepatic failure in adult onset Still's diseaseQ71322293
Liver transplant in adult Still's diseaseQ73789431
Humanized monoclonal anti-interleukin-6 receptor antibody for treatment of intractable adult-onset Still's diseaseQ78667433
Macrophage activation syndrome following initiation of etanercept in a child with systemic onset juvenile rheumatoid arthritisQ78874963
Cardiac tamponade: a life-threatening complication of Still's diseaseQ79235218
The diagnostic significance of soluble CD163 and soluble interleukin-2 receptor alpha-chain in macrophage activation syndrome and untreated new-onset systemic juvenile idiopathic arthritisQ79844555
Pulmonary hypertension in a patient with adult-onset Stills diseaseQ80001180
P433issue3
P921main subjectadult-onset Still's diseaseQ1187697
P304page(s)305-314
P577publication date2014-01-17
P1433published inClinical RheumatologyQ15754927
P1476titleLife-threatening complications of adult-onset Still's disease
P478volume33

Reverse relations

cites work (P2860)
Q92482917Acquired Amegakaryocytic Thrombocytopenia in Adult-onset Still's Disease: Successful Combination Therapy with Tocilizumab and Cyclosporine
Q28079446Adult-onset Still's disease: current challenges and future prospects
Q36208563Adult-onset Still's disease: evaluation of prognostic tools and validation of the systemic score by analysis of 100 cases from three centers
Q38637780Advances in immunopathogenesis of macrophage activation syndrome during rheumatic inflammatory diseases: toward new therapeutic targets?
Q90550872Are the 2016 EULAR/ACR/PRINTO classification criteria for macrophage activation syndrome applicable to patients with adult-onset Still's disease?
Q48362160Clinical and histopathological features of cutaneous manifestations of adult-onset Still disease.
Q38530013Clinical features and correct diagnosis of macrophage activation syndrome.
Q55109011Diagnostic and management of life-threatening Adult-Onset Still Disease: a French nationwide multicenter study and systematic literature review.
Q40630580Epidemiological study of adult-onset Still's disease using a Japanese administrative database
Q47727637H-ferritin and proinflammatory cytokines are increased in the bone marrow of patients affected by macrophage activation syndrome.
Q64039508Long-Term Retention Rate of Anakinra in Adult Onset Still's Disease and Predictive Factors for Treatment Response
Q48340351Macrophage activation syndrome in Still's disease: analysis of clinical characteristics and survival in paediatric and adult patients.
Q64235820Managing Adult-onset Still's disease: The effectiveness of high-dosage of corticosteroids as first-line treatment in inducing the clinical remission. Results from an observational study
Q57143910Mechanisms, biomarkers and targets for adult-onset Still's disease
Q34042413Pathogenesis of adult-onset Still's disease: new insights from the juvenile counterpart.
Q26830024Pathophysiology, subtypes, and treatments of adult-onset Still's disease: An update
Q38463009Presentation and diagnosis of adult-onset Still's disease: the implications of current and emerging markers in overcoming the diagnostic challenge.
Q97653199Pro-inflammatory properties of H-ferritin on human macrophages, ex vivo and in vitro observations
Q37053491Pulmonary arterial hypertension secondary to adult-onset Still's disease: Response to cyclosporine and sildenafil over 15 years of follow-up
Q47160193Refractory Adult Onset Still’s Disease
Q50352247Severe Pulmonary Hypertension Due to Adult-Onset Still's Disease.
Q38925320The Use of Cyclosporine A in Rheumatology: a 2016 Comprehensive Review
Q39445471Tocilizumab for uncontrollable systemic inflammatory response syndrome complicating adult-onset Still disease: Case report and review of literature
Q34043097Treatment of adult-onset Still's disease: a review
Q38679486Treatment of adult-onset still's disease: up to date.
Q42240996Unusual manifestations and unusual mimics of adult onset Still's disease.